Abstract:CD155 is highly expressed in hepatocellular carcinoma (HCC) tissues, and its overexpression predicts poor postsurgery prognosis in HCC patients.CD155 promotes HCC progression via its cell‐intrinsic role in regulating cell proliferation, migration, invasion and epithelial–mesenchymal transition (EMT).CD155 enhances SRC activation through interacting with SH2 domain of SRC, further inhibiting the downstream p38 MAPK signalling pathway in HCC.BackgroundHepatocellular carcinoma (HCC) is a prevalent malignancy with poor prognosis. As a cell adhesion molecule, poliovirus receptor (PVR/CD155) is abnormally overexpressed in tumour cells, and related to tumour proliferation and invasion. However, the potential role and mechanism of CD155 have not yet been elucidated in HCC.MethodsImmunohistochemistry, RT‐PCR and Western blot assays were used to determine CD155 expression in HCC cell lines and tissues. Cell Counting Kit‐8 and colony formation assays were used to examine cell proliferation. Transwell and wound healing assays were used to evaluate cell migration and invasion. Cell apoptosis and cycle distribution were assessed by flow cytometry. Cox regression and Kaplan–Meier analyses were performed to explore the clinical significance of CD155. The role of CD155 in vivo was evaluated by establishing liver orthotropic xenograft mice model. RNA sequencing, bioinformatics analysis and co‐immunoprecipitation assay were used to explore the downstream signalling pathway of CD155.ResultsCD155 was upregulated in HCC tissues and represented a promising prognostic indicator for HCC patients (n = 189) undergoing curative resection. High CD155 expression enhanced cell proliferation, migration and invasion, and contributed to cell survival in HCC. CD155 overexpression also induced epithelial–mesenchymal transition in HCC cells. CD155 function in HCC involved SRC/p38 MAPK signalling pathway. CD155 interacted with SRC homology‐2 domain of SRC and promoted SRC activation, further inhibiting the downstream p38 MAPK signalling pathway in HCC.ConclusionsCD155 promotes HCC progression via the SRC/p38 MAPK signalling pathway. CD155 may represent a predictor for poor postsurgery prognosis in HCC patients.

Prostate-derived ETS Factor Improves Prognosis and Represses Proliferation and Invasion in Hepatocellular Carcinoma

IDDF2019-ABS-0269 Overexpression of PDEF Suppresses Cell Aggressiveness in Colorectal Cancer

An E2F1/DDX11/EZH2 Positive Feedback Loop Promotes Cell Proliferation in Hepatocellular Carcinoma

Pigment Epithelium-Derived Factor Promotes Tumor Metastasis Through an Interaction with Laminin Receptor in Hepatocellular Carcinomas

The contrary intracellular and extracellular functions of PEDF in HCC development

DEPDC1 Promotes Cell Proliferation and Tumor Growth Via Activation of E2F Signaling in Prostate Cancer

DEP domain containing 1B (DEPDC1B) exerts the tumor promoter in hepatocellular carcinoma through activating p53 signaling pathway via kinesin family member 23 (KIF23)

Eef1a1 Overexpression Enhances Tumor Progression and Indicates Poor Prognosis in Hepatocellular Carcinoma.

EDG2 Enhanced the Progression of Hepatocellular Carcinoma by LPA/PI3K/AKT/ Mtor Signaling.

Protein Tyrosine Phosphatase Receptor S Acts As a Metastatic Suppressor in Hepatocellular Carcinoma by Control of Epithermal Growth Factor Receptor-Induced Epithelial-Mesenchymal Transition.

E2F4 Promotes the Proliferation of Hepatocellular Carcinoma Cells through Upregulation of CDCA3

SPDEF drives pancreatic adenocarcinoma progression via transcriptional upregulation of S100A16 and activation of the PI3K/AKT signaling pathway

Alpha-fetoprotein upregulates hepatocellular carcinoma cell-intrinsic PD-1 expression through the LATS2/YAP/TEAD1 pathway

High-expressed PTPN1 Promotes Tumor Proliferation Signature in Human Hepatocellular Carcinoma

Reduced Expression of CENP-E Contributes to the Development of Hepatocellular Carcinoma and is Associated with Adverse Clinical Features

Clinical Implication of E2F Transcription Factor 1 in Hepatocellular Carcinoma Tissues

DEPDC1 Drives Hepatocellular Carcinoma Cell Proliferation, Invasion and Angiogenesis by Regulating the CCL20/CCR6 Signaling Pathway

Dihydropyrimidine dehydrogenase predicts survival and response to interferon-α in hepatocellular carcinoma

DEPTOR induces a partial epithelial-to-mesenchymal transition and metastasis via autocrine TGFβ1 signaling and is associated with poor prognosis in hepatocellular carcinoma

CD155/SRC complex promotes hepatocellular carcinoma progression via inhibiting the p38 MAPK signalling pathway and correlates with poor prognosis

Tumoral EHF Predicts the Efficacy of Anti-Pd1 Therapy in Pancreatic Ductal Adenocarcinoma